MARC record from Internet Archive

LEADER: 05920cam 2201165 a 4500
001 ocm28749128
003 OCoLC
005 20200422000312.0
008 930816s1994 gw a b 001 0 eng
010 $a 93006449
040 $aDNLM/DLC$beng$cDLC$dNLM$dTMV$dNLGGC$dBAKER$dBTCTA$dYDXCP$dOCLCG$dGEBAY$dZWZ$dBDX$dOCLCO$dOCLCQ$dDEBBG$dOCLCQ$dOCLCF$dOCLCO$dAU@$dUKMGB$dOCLCQ$dOCLCA
016 7 $a9314211$2DNLM
016 7 $a006203069$2Uk
019 $a232128429
020 $a3540571213$q(Berlin ;$qacid-free paper)
020 $a9783540571216$q(Berlin ;$qacid-free paper)
020 $z0387571213$q(New York ;$qacid-free paper)
020 $a9780387571218
020 $a0387571213
035 $a(OCoLC)28749128$z(OCoLC)232128429
050 00 $aQP905$b.H3 vol. 109$aRC632.L54
060 00 $aW1$bHA51L v.109 1994
060 10 $aWD 200.5.H8$bP957 1994
082 00 $a615/.1 s$a616.3/997$220
084 $a44.77$2bcl
084 $aXI 1701$2rvk
084 $aYC 7400$2rvk
084 $aMED 441f$2stub
084 $aQV 4$2sdnb
245 00 $aPrinciples and treatment of lipoprotein disorders /$ccontributors, D.H. Blankenhorn [and others] ; editors, Gotthard Schettler and Andreas J.R. Habenicht.
260 $aBerlin ;$aNew York :$bSpringer-Verlag,$c℗♭1994.
300 $axxiii, 502 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aHandbook of experimental pharmacology ;$vv. 109
504 $aIncludes bibliographical references and index.
505 0 $aPhysiology and pathophysiology of lipid metabolism -- Introduction to the biochemistry and biology of blood lipids and lipoproteins / J.R. Patsch -- Lipoprotein metabolism / H.B. Brewer -- Lipoproteins receptors / W.J.S. de Villiers, G.A. Coetzee, D.R. van der Westhuyzen -- Genetic disorders of lipoprotein metabolism / G. Utermann, H.J. Menzel -- Interactions between lipoproteins and the arterial wall / A.J.R. Habenicht, P.B. Salbach, U. Janssen-Timmen -- Lipoprotein lipase and hepatic lipase / T. Olivecrona, G. Olivecrona -- Animal models of lipoprotein metabolism / D. Dritchevsky -- Lipid lowering therapy -- Rationale to treat / D.H. Blankenhorn, H.N. Hodis -- Dietary therapy of hyperlipidemia: its important role in the prevention of coronary heart disease / W.E. Connor, S.L. Connor -- Lipid apheresis / D. Seidel -- Lipid lowering drugs -- 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors / D.R. Illingworth, E.B. Schmidt -- Fibrates / A. Gaw, C.J. Packard, J. Shepherd -- Nicotinic acid and derivatives / A.G. Olsson.
505 0 $a(cont) Ion exchange resins / P. Schwandt, W.O. Richter -- Probucol / J. Davignon -- Miscellaneous lipid-lowering drugs / K.J. Lackner, E. von Hodenberg.
650 0 $aLipoproteins$xMetabolism$xDisorders$xTreatment.
650 0 $aLipoproteins$xMetabolism$xDisorders$xChemotherapy.
650 0 $aAntilipemic agents.
650 12 $aHyperlipidemias$xdiet therapy.
650 12 $aHyperlipidemias$xdrug therapy.
650 22 $aCoronary Disease$xprevention & control.
650 22 $aLipid Metabolism.
650 7 $aLipoproteins.$2cabt
650 7 $aMetabolism.$2cabt
650 7 $aMetabolic Disorders.$2cabt
650 7 $aHyperlipoproteinaemia.$2cabt
650 7 $aDrug Therapy.$2cabt
650 7 $aAntilipemic agents.$2fast$0(OCoLC)fst00810544
650 7 $aLipoprote ines$xphysiopathologie.$2fmesh
650 7 $aAntilipe miants.$2fmesh
650 7 $aMaladie coronaire$xpre vention et contro le.$2fmesh
650 7 $aHyperlipide mies$xTraitement me dicamenteux.$2fmesh
650 7 $aHyperlipide mies$xDie tothe rapie.$2fmesh
650 7 $aLipides$xMe tabolisme.$2fmesh
650 7 $aBlut$2gnd
650 7 $aHyperlipida mie$2gnd
650 7 $aLipidstoffwechsel$2gnd
650 7 $aLipidstoffwechselsto rung$2gnd
650 7 $aLipoproteide$2gnd
650 7 $aRezeptor$2gnd
650 7 $aSto rung$2gnd
650 7 $aTherapie$2gnd
650 17 $aLipoprotei nen.$2gtt
650 17 $aStofwisselingsziekten.$2gtt
650 17 $aHyperlipidemie.$2gtt
650 17 $aFarmacotherapie.$2gtt
650 7 $aProbucol.$2ram
650 7 $aHyperlipide mie$xThe rapeutique.$2ram
650 7 $aLipoprote ines$xMe tabolisme.$2ram
650 7 $aLipoprote ines$xPhysiopathologie.$2ram
650 7 $aLipoprote ines$xMe tabolisme, Troubles du.$2ram
650 7 $aLipoprote ines$xMe tabolisme, Troubles du$xThe rapeutique.$2ram
650 7 $aLipoprote ines$xDie tothe rapie.$2ram
650 7 $aHypolipe miants.$2ram
650 07 $aTherapie.$2swd
700 1 $aBlankenhorn, David H.
700 1 $aSchettler, Gotthard.
700 1 $aHabenicht, A.$q(Andreas),$d1948-
776 08 $iOnline version:$tPrinciples and treatment of lipoprotein disorders.$dBerlin ; New York : Springer-Verlag, ℗♭1994$w(OCoLC)607737410
776 08 $iOnline version:$tPrinciples and treatment of lipoprotein disorders.$dBerlin ; New York : Springer-Verlag, ℗♭1994$w(OCoLC)622296592
830 0 $aHandbook of experimental pharmacology ;$vv. 109.
856 41 $3Table of contents$uhttp://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005864311&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
856 4 $31850-9999$uhttp://www.springer.com/gb/$xBLDSS
938 $aBaker & Taylor$bBKTY$c450.00$d450.00$i0387571213$n0002384875$sactive
938 $aBrodart$bBROD$n47002697$c$350.00
938 $aBaker and Taylor$bBTCP$n93006449$cDM510.00
938 $aYBP Library Services$bYANK$n325103
029 1 $aAU@$b000010425809
029 1 $aDEBBG$bBV008865919
029 1 $aGEBAY$b2126169
029 1 $aNLGGC$b111034426
029 1 $aNLM$b9314211
029 1 $aNZ1$b4256288
029 1 $aUKMGB$b006203069
994 $aZ0$bP4A
948 $hHELD BY P4A - 147 OTHER HOLDINGS